AbbVie
ABBV
#27
Rank
$337.52 B
Marketcap
$191.08
Share price
-0.70%
Change (1 day)
14.72%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

EPS for AbbVie (ABBV)

EPS in 2025 (TTM): $2.36

According to AbbVie's latest financial reports the company's current EPS (TTM) is $2.36. In 2024 the company made an earnings per share (EPS) of $2.41 a decrease over its 2023 EPS that were of $2.75.

EPS history for AbbVie from 2013 to 2025

Annual EPS

Year EPS Change
2025 (TTM)$2.36-2.08%
2024$2.41-12.39%
2023$2.75-58.95%
2022$6.692.49%
2021$6.53121.58%
2020$2.95-44.7%
2019$5.3345.84%
2018$3.669.72%
2017$3.33-9.54%
2016$3.6816.28%
2015$3.17184.1%
2014$1.11-57.15%
2013$2.60

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
$1.39-41.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$2.68 13.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$12.36 424.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
$11.05 368.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
$4.78 102.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
$10.16 330.96%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
$1.56-33.85%๐Ÿ‡ฌ๐Ÿ‡ง UK
AstraZeneca
AZN
$2.50 6.25%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
$3.03 28.52%๐Ÿ‡บ๐Ÿ‡ธ USA
OSZAR »